JPS6127045B2 - - Google Patents
Info
- Publication number
- JPS6127045B2 JPS6127045B2 JP53023391A JP2339178A JPS6127045B2 JP S6127045 B2 JPS6127045 B2 JP S6127045B2 JP 53023391 A JP53023391 A JP 53023391A JP 2339178 A JP2339178 A JP 2339178A JP S6127045 B2 JPS6127045 B2 JP S6127045B2
- Authority
- JP
- Japan
- Prior art keywords
- insole
- antifungal agent
- organic
- organic polymer
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940121375 antifungal agent Drugs 0.000 claims description 17
- 239000003429 antifungal agent Substances 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 11
- -1 2,4,5-trichlorophenyl iodine propargyl ester Chemical class 0.000 claims description 7
- 229920000620 organic polymer Polymers 0.000 claims description 7
- 239000002861 polymer material Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 3
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 claims description 2
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 claims description 2
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 claims description 2
- 229960002867 griseofulvin Drugs 0.000 claims description 2
- DXKCSDJDDJIOES-UHFFFAOYSA-N 11-iodoundec-10-ynoic acid Chemical compound OC(=O)CCCCCCCCC#CI DXKCSDJDDJIOES-UHFFFAOYSA-N 0.000 claims 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 1
- 239000000463 material Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 201000004647 tinea pedis Diseases 0.000 description 4
- 239000000945 filler Substances 0.000 description 3
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- QYRCYLIYZMESCE-CSKARUKUSA-N (E)-11-iodoundec-10-enoic acid Chemical compound OC(=O)CCCCCCCC\C=C\I QYRCYLIYZMESCE-CSKARUKUSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Description
【発明の詳細な説明】
本発明は水虫治療薬である抗真菌剤を含有する
インソール(靴の中敷)に関する。更に詳しくは
インソールに成形された有機高分子物質に特定の
抗真菌剤を混合・分散・コーテイングせしめた水
虫治療効果をもつインソールに係る。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an insole (shoe insole) containing an antifungal agent that is a therapeutic agent for athlete's foot. More specifically, the present invention relates to an insole having a therapeutic effect on athlete's foot, in which a specific antifungal agent is mixed, dispersed, and coated in an organic polymer material molded into the insole.
従来の水虫薬は粉末,液状あるいは軟膏の形態
で患部に塗布されているが、本発明の方法はイン
ソールを基体として抗真菌剤を足部に応用する新
型式のドラツグデリバリー方式である。 Conventional athlete's foot medicines are applied to the affected area in the form of powder, liquid, or ointment, but the method of the present invention is a new type of drug delivery method in which the antifungal agent is applied to the foot using an insole as a base.
本発明は低分子物の抗真菌剤が高分子物中に混
合分散し成型されたとき、時間の経過と共に徐々
にマイグレーシヨンを起して高分子物質の表面に
析出する現象を利用したものである。工業的にこ
の現象は製品の品質劣化の問題と関係があるため
に好まれるものではない。従つて、相溶性を有す
る有機物を混合するとか、混合を充分行うことに
より安定化を図るとか、混合低分子物を高分子化
するなどの種々の改良法が提案され、かつ実用化
されている。本発明は、低分子物の揮散する現象
を積極的に利用して皮膚に対して薬の長期的な放
出効果を与えようとするものである。 The present invention utilizes the phenomenon that when a low-molecular antifungal agent is mixed and dispersed in a polymeric material and molded, it gradually migrates over time and precipitates on the surface of the polymeric material. be. Industrially, this phenomenon is not preferred because it is associated with the problem of product quality deterioration. Therefore, various improvement methods have been proposed and put into practical use, such as mixing compatible organic substances, stabilizing the mixture by thorough mixing, and converting mixed low-molecular substances into polymers. . The present invention aims to provide a long-term drug release effect to the skin by actively utilizing the phenomenon of volatilization of low molecular weight substances.
周知の如く白癬菌は表皮内に巣食つているか
ら、皮膚表面に薬剤を塗布することによつて治療
効果を得る為には、長時間皮膚表面に薬が滞留す
る必要がある。それによつて汗腺や皮脂等を経由
して表皮内に治療薬が吸収され治療効果が現われ
るものである。インソールを薬の供給母体とする
ことは、日中7〜8時間の皮膚との接触時間が期
待されるので接触時間に関しては充分である。 As is well known, Trichophyton burrows within the epidermis, so in order to obtain a therapeutic effect by applying a drug to the skin surface, the drug must remain on the skin surface for a long time. As a result, the therapeutic drug is absorbed into the epidermis via sweat glands, sebum, etc., and the therapeutic effect appears. When the insole is used as a drug delivery base, the contact time with the skin is expected to be 7 to 8 hours during the day, so the contact time is sufficient.
抗真菌剤としては、ハロゲン化フエノール系,
抗生物質系,脂肪酸系及びナフチオメート系の抗
真菌剤よりなる群から選ばれた少くとも1種の抗
真菌剤が用いられる。 Antifungal agents include halogenated phenols,
At least one antifungal agent selected from the group consisting of antibiotic, fatty acid, and naphthiomate antifungal agents is used.
具体的例としては、例えば2,4,5−トリク
ロロフエニルアイオダインプロパルギルエステ
ル,グリセオフルビン,11−ヨード−10−ウンデ
シン酸,2,4,6−トリブロムフエニルカプロ
ン酸エステル,α−ナフチール−N−メチール−
N−β−ナフチルチオノカルバメート等を好適な
ものとして拳げることができるがこれに限定され
るものではない。 Specific examples include 2,4,5-trichlorophenyl iodine propargyl ester, griseofulvin, 11-iodo-10-undecic acid, 2,4,6-tribromphenylcaproic acid ester, α-naphthyl- N-methyl-
Suitable examples include N-β-naphthylthionocarbamate, but the present invention is not limited thereto.
これらの抗真菌剤は有機高分子物質に対して
0.01〜5%(重量)適用する。混合量は多い程薬
効は上るが、有機分子物質にフイラー,分散剤な
どと抗菌剤を分散混合すると、その成形性から5
%程度の限界があつて実用上適当な濃度は1〜2
%となる。 These antifungal agents are effective against organic polymeric substances.
Apply 0.01-5% (by weight). The greater the mixing amount, the higher the medicinal efficacy, but when fillers, dispersants, etc. and antibacterial agents are dispersed and mixed into organic molecular substances, the moldability
There is a limit of about 1%, and the practically appropriate concentration is 1 to 2%.
%.
有機高分子物質としては、天然ゴム,ポリイソ
プレン,ポリウレタン,ポリアクリロニトリル,
ポリエチレングリコールテレフタレート,ポリス
チレン,ポリエチレン,ポリプロピレン等が挙げ
られる。有機高分子物質として必要な特性条件と
しては、成形性,熱安定性,熱可塑性,インソー
ルに使用したときの物理的,化学的使用に耐える
強度,強靭性,耐寒性等の保有していることが必
要となる。 Organic polymer substances include natural rubber, polyisoprene, polyurethane, polyacrylonitrile,
Examples include polyethylene glycol terephthalate, polystyrene, polyethylene, polypropylene, and the like. The properties necessary for an organic polymer material include moldability, thermal stability, thermoplasticity, strength to withstand physical and chemical use when used in insoles, toughness, and cold resistance. Is required.
製品製造上必要な物質としては、有機高分子物
質の物理的性質の向上とコストダウンを目的とし
たフイラー類である、例えばクレイ,炭酸マグネ
シウム,酸化硅素,塩化カルシウム等を必要に応
じて高分子物質基体に1〜40%(重量)混合せし
めることが好ましい。 Materials necessary for product manufacturing include fillers such as clay, magnesium carbonate, silicon oxide, calcium chloride, etc., which are used to improve the physical properties of organic polymer materials and reduce costs. It is preferable to mix 1 to 40% (by weight) into the material substrate.
抗真菌剤と有機高分子物質の混合をより能率よ
く、しかも均一に行う目的で、抗真菌剤を活性白
土や活性炭等の吸着剤に吸着させたのちに混合す
ることもできる。これらの吸着剤は前述のフイラ
ーとしての効果を有するものもある。インソール
として使用中悪臭を吸着する効果も有する。 In order to mix the antifungal agent and the organic polymer substance more efficiently and uniformly, the antifungal agent may be adsorbed onto an adsorbent such as activated clay or activated carbon and then mixed. Some of these adsorbents have the effect as the filler described above. It also has the effect of absorbing bad odors when used as an insole.
有機高分子物質と抗真菌剤の混合方法は有機高
分子物質よりインソールを成型する工程によつて
変化する。本発明のコーテイング法の例をその例
を以下に説明する。 The method of mixing the organic polymeric material and the antifungal agent changes depending on the process of molding the insole from the organic polymeric material. An example of the coating method of the present invention will be described below.
あらかじめ、織目の荒い織物,フイルム,ビス
コーススポンジ又はポリウレタン発泡体をインソ
ールの型に打抜き、必要があれば前述のラミネー
トしたインソールを得る。 In advance, a coarsely woven fabric, film, viscose sponge, or polyurethane foam is punched into an insole mold, and if necessary, the laminated insole described above is obtained.
このインソールの片面又は両面に溶剤に溶かし
た抗真菌剤を附着・浸漬することからインソール
内に薬剤を含浸せしめ得る。この方法で最も好ま
しい実施態様は溶媒と該溶媒に可溶な有機高分子
物質と抗真菌剤とからなる混合溶液をインソール
の片面又は両面にコーテイングする。コーテイン
グ後、乾燥して溶媒を除却し、水虫治療効果のあ
るインソールを得る。 By applying or dipping an antifungal agent dissolved in a solvent onto one or both sides of the insole, the insole can be impregnated with the agent. In the most preferred embodiment of this method, one or both sides of the insole is coated with a mixed solution consisting of a solvent, an organic polymeric substance soluble in the solvent, and an antifungal agent. After coating, the insole is dried to remove the solvent and obtain an insole with anti-athlete's foot effect.
実施例として、酢酸繊維素のアセトン10%の溶
液を作り、これに酢酸繊維素の重量に対して2%
の11−ヨード−10−ウンデシレン酸を溶解した。
これをインソールの形の深さ5mm鉄製の型に流し
込み、60℃にて1時間乾燥した。型よりとり出し
厚さ約0.5mの抗真菌剤含有のインソールが得ら
れた。 As an example, a 10% acetone solution of cellulose acetate was prepared, and 2% of the weight of cellulose acetate was added to the solution.
of 11-iodo-10-undecylenic acid was dissolved.
This was poured into an insole-shaped iron mold with a depth of 5 mm and dried at 60°C for 1 hour. The insole containing the antifungal agent was removed from the mold and had a thickness of approximately 0.5 m.
Claims (1)
であつて、2,4,5−トリクロロフエニルアイ
オダインプロパルギルエステル,グリセオフルビ
ン,11−ヨード−10−ウンデシン酸,2,4,6
−トリブロムフエニルカプロン酸エステル,α−
ナフチール−N−メチール−N−β−ナフチルチ
オノカルバメートよりなる群から選ばれた少なく
とも1種の抗真菌剤が0.01〜5.0%(重量)の割
合で有機高分子物質の表面にコーテイングせしめ
られてなるインソール。 2 主として有機高分子物質からなるインソール
であつて、ハロゲン化フエノール系抗真菌剤及び
ナフチオメート系抗真菌剤が全量で0.01〜5.0%
(重量)の割合で有機高分子物質の表面にコーテ
イングせしめられてなるインソール。[Scope of Claims] 1. An insole mainly composed of an organic polymeric substance, which comprises 2,4,5-trichlorophenyl iodine propargyl ester, griseofulvin, 11-iodo-10-undecynic acid, 2,4,6
-Tribromphenylcaproic acid ester, α-
At least one antifungal agent selected from the group consisting of naphthyl-N-methyl-N-β-naphthylthionocarbamate is coated on the surface of the organic polymer material at a ratio of 0.01 to 5.0% (by weight). An insole. 2 An insole mainly composed of organic polymeric substances, with a total content of 0.01 to 5.0% of halogenated phenolic antifungal agents and naphthiomate antifungal agents.
An insole made by coating the surface of an organic polymer material in a proportion of (by weight).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2339178A JPS54117258A (en) | 1978-03-01 | 1978-03-01 | Insole containing anti-eumycetes agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2339178A JPS54117258A (en) | 1978-03-01 | 1978-03-01 | Insole containing anti-eumycetes agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS54117258A JPS54117258A (en) | 1979-09-12 |
JPS6127045B2 true JPS6127045B2 (en) | 1986-06-24 |
Family
ID=12109202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2339178A Granted JPS54117258A (en) | 1978-03-01 | 1978-03-01 | Insole containing anti-eumycetes agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS54117258A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020032165A1 (en) | 2018-08-08 | 2020-02-13 | 国立大学法人 東京大学 | Conjugate of biotin variant dimer with phthalocyanine pigment |
WO2020138427A1 (en) | 2018-12-28 | 2020-07-02 | 国立大学法人 東京大学 | Fusion protein of streptavidin variant and antibody recognizing cancer cells |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58190004U (en) * | 1982-06-14 | 1983-12-17 | 帝三製薬株式会社 | footwear |
JPS59169834U (en) * | 1983-04-28 | 1984-11-13 | 井上 鉄彦 | Paste for disinfection, mold prevention, and deodorization inside footwear |
JPS62114504A (en) * | 1985-11-15 | 1987-05-26 | 株式会社 フアラオン | Insole of footwear |
JPS6411504A (en) * | 1987-07-07 | 1989-01-17 | Teisan Seiyaku Kk | Method for sterilizing and deodorizing interior of shoes and insole used therein |
JPH02116302A (en) * | 1988-10-26 | 1990-05-01 | Katsutoshi Hegi | Shoe insole having deodorizing and sterilizing properties |
-
1978
- 1978-03-01 JP JP2339178A patent/JPS54117258A/en active Granted
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020032165A1 (en) | 2018-08-08 | 2020-02-13 | 国立大学法人 東京大学 | Conjugate of biotin variant dimer with phthalocyanine pigment |
WO2020138427A1 (en) | 2018-12-28 | 2020-07-02 | 国立大学法人 東京大学 | Fusion protein of streptavidin variant and antibody recognizing cancer cells |
Also Published As
Publication number | Publication date |
---|---|
JPS54117258A (en) | 1979-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU609398B2 (en) | Drug delivery device, its preparation and use | |
CN100374161C (en) | Triacetin as a transdermal penetration enhancer | |
US4191743A (en) | Antibacterial wound dressing | |
EP2002824B1 (en) | Gel composition and use thereof | |
US20060188558A1 (en) | Transdermal systems having control delivery system | |
PT81751A (en) | Process for the manufacture of transdermal drug patches | |
PT92652B (en) | METHOD FOR PREPARING A TRANSDERMM THERAPEUTIC SYSTEM CONTAINING PHYSOSTIGMINE AS ACTIVE INGREDIENT | |
US8440222B2 (en) | Reservoir system with closed membrane | |
KR910007508A (en) | Sustained release dressings and uses thereof | |
PT1613297E (en) | Therapeutic patch with polysiloxane matrix comprising capsaicin | |
JP2007520614A (en) | Medicinal polyurethane foam | |
JPS6127045B2 (en) | ||
JPS6158446B2 (en) | ||
EP0082880B1 (en) | Polymeric diffusion matrix containing propranolol | |
JPH09268123A (en) | Cataplasm for local anesthesia | |
CN103232819B (en) | Adhesive preparation | |
JPS6320344A (en) | Resin composition which slowly releases antibacterial agent | |
CN1149976C (en) | Adhesive polymer substrate and its application | |
CN102475692A (en) | Transdermal patch preventing rasagiline from volatilizing | |
JPS61255601A (en) | Insole | |
JPS6027304B2 (en) | Sheet deodorizer | |
EP2127644B1 (en) | Gel composition for medical material or hygiene material, molded article thereof and adhesive material or adhesive preparation using same | |
JPH02250826A (en) | Bandage for oral application | |
JP2004010524A (en) | Medicine holding material and affected part treating material | |
JPS60185504A (en) | Insole of shoes |